| |
| |
|
| Insider
Information: |
Fouse Jacqualyn A |
| Relationship: |
Director |
| City: |
White Plains |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
288,702 |
|
|
Indirect Shares
|
1,448 |
|
|
| Direct
Value |
$24,997,174 |
|
|
|
Indirect Value
|
$156,732 |
|
|
| Total
Shares |
290,150 |
|
|
| Total
Value |
$25,153,906 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 6.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bunge Ltd |
BG |
Chief Financial Officer |
2010-09-02 |
0 |
2007-07-23 |
0 |
Premium* |
|
|
Celgene Corp |
CELG |
see remarks, Director |
2016-12-02 |
82,040 |
2016-12-02 |
1,448 |
Premium* |
|
|
Dicks Sporting Goods Inc |
DKS |
Director |
2020-03-22 |
55,288 |
2011-03-15 |
0 |
Premium* |
|
|
Perrigo Co |
PRGO |
Director |
2013-12-18 |
0 |
2012-11-14 |
0 |
Premium* |
|
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
13,978 |
2018-03-29 |
0 |
Premium* |
|
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2024-04-10 |
137,396 |
2019-05-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
103 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2019-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,400 |
1,400 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2020-04-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,379 |
54,101 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2020-04-14 |
4 |
D |
$40.64 |
$149,271 |
D/D |
(3,673) |
50,428 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2021-02-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,398) |
58,363 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2021-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,333 |
61,761 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2022-02-14 |
4 |
D |
$30.50 |
$106,903 |
D/D |
(3,505) |
66,192 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2022-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,334 |
69,697 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,379 |
78,571 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2022-02-22 |
4 |
D |
$29.08 |
$106,840 |
D/D |
(3,674) |
74,897 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2023-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,333 |
86,230 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2023-02-16 |
4 |
D |
$28.91 |
$105,464 |
D/D |
(3,648) |
82,582 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2023-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,933 |
98,515 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2023-04-12 |
4 |
D |
$21.35 |
$101,007 |
D/D |
(4,731) |
93,784 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2023-06-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,900 |
117,684 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2023-06-30 |
4 |
S |
$28.36 |
$303,962 |
D/D |
(10,718) |
106,966 |
0 |
% |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2024-01-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,500 |
124,466 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2024-01-09 |
4 |
AS |
$22.99 |
$192,909 |
D/D |
(8,391) |
116,075 |
0 |
% |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2024-01-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,900 |
139,975 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2024-01-24 |
4 |
AS |
$21.64 |
$232,024 |
D/D |
(10,722) |
129,253 |
0 |
% |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2024-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,934 |
145,187 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2024-04-10 |
4 |
AS |
$27.55 |
$214,642 |
D/D |
(7,791) |
137,396 |
0 |
% |
|
| BG |
Bunge Ltd |
Chief Financial Officer |
• – – |
2007-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| BG |
Bunge Ltd |
Chief Financial Officer |
• – – |
2007-08-31 |
4 |
A |
$91.23 |
$8,484 |
D/D |
93 |
50,093 |
0 |
- |
|
| BG |
Bunge Ltd |
Chief Financial Officer |
• – – |
2007-11-30 |
4 |
A |
$112.61 |
$8,445 |
D/D |
75 |
50,168 |
0 |
- |
|
| BG |
Bunge Ltd |
Chief Financial Officer |
• – – |
2008-02-29 |
4 |
A |
$110.75 |
$8,527 |
D/D |
77 |
50,245 |
0 |
- |
|
103 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
